The global quinidine sulfate market is anticipated to grow at a significant CAGR during the forecast period. Quinidine sulfate is used for the treatment of certain types of irregular heartbeats. It is in a class of medications called antiarrhythmic medications and works by making the heart more resistant to abnormal activity. The major factor driving the demand for quinidine sulfate is the increasing prevalence of arrhythmia and other diseases such as malaria that require quinidine sulfate treatment across the globe.
Moreover, the growth of the market can also be attributed to the increasing awareness of the usage and appropriate dosage of quinidine sulfate supplements among people globally. Additionally, the function of quinidine sulfate involves blocking the fast inward sodium current that is dependent upon the use. For instance, at higher heart rates, the block increases, and at lower heart rates, the block decreases. Further, the growth of the market is hampered due to side effects associated with quinidine sulfate such as diarrhea, nausea, vomiting, loss of appetite, stomach pain/cramps, among others.
Some major players in the market include Pfizer Inc., Novartis International AG, and Lupin Ltd., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in March 2019, Avanir Pharmaceuticals, Inc. announced the results from the first study of its phase 3 clinical development program investigating the efficacy, safety, and tolerability of AVP-786 (deudextromethorphan hydrobromide [d6-DM]/quinidine sulfate [Q]) for the treatment of moderate-to-severe agitation in patients with Alzheimer’s dementia.
To Request a Sample of our Report on Quinidine Sulfate Market: https://www.omrglobal.com/request-sample/quinidine-sulfate-market
Market Coverage
- The market number available for – 2021-2029
- Base year- 2021
- Forecast period- 2023-2029
Segment Covered-
- By Route of Administration
- By Application
- By End-User
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape- Pfizer Inc., Novartis International AG, and Lupin Ltd., among others.
Quinidine Sulfate Market Report by Segment
By Route of Administration
- Oral Administration
- Intravenous Administration
- Others
By Application
- Arrhythmias
- Malaria
- Others
By End-User
- Pediatrics
- Adults
A full Report of Quinidine Sulfate Market is Available @ https://www.omrglobal.com/industry-reports/quinidine-sulfate-market
Quinidine Sulfate Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
